The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Transdermal deferoxamine prevents pressure-induced diabetic ulcers
Open accessAbstract
Significance: Diabetes is the leading cause of nontraumatic amputations. There are no effective therapies to prevent diabetic ulcer formation and only modestly effective technologies to help with their healing. To enhance diabetic wound healing we designed a transdermal delivery system containing the FDA-approved small molecule deferoxamine, an iron chelator that increases defective hypoxia inducible factor-1 alpha transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress. This system overcomes the challenge of delivering hydrophilic molecules through the normally impermeable stratum corneum and both prevents diabetic ulcer formation and improves the healing of existing diabetic wounds. This represents a prophylactic pharmacological agent to prevent ulcer formation that is rapidly translatable into the clinic and has the potential to ultimately transform the care and prevention of diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Self-citationOxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Self-citationEconomic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 1×
“Moreover, DFO reduction of free radical formation decreased cell death (20, 21).”
BackgroundProgenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600 · cited 11×
“Hypoxia inducible factor-1 (HIF-1), which consists of a highly regulated α-subunit and a constitutively expressed β-subunit, is a critical transcriptional regulator of the normal cellular response to hypoxia, promoting progenitor cell recruitment, proliferation, survival, and neovascularization (14, 15).”
BackgroundInfluentialSelf-citationAndrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
The molecular biology of chronic wounds and delayed healing in diabetes
Blakytny, R., & Jude, E. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01773.x · Cited by 632
Stabilization of HIF-1α is critical to improve wound healing in diabetic mice
Botusan, I. R., Sunkari, V. G., Savu, O., Catrina, A. I., Grünler, J., Lindberg, S., Pereira, T., Ylä-Herttuala, S., Poellinger, L., Brismar, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805230105 · Cited by 533
Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals
Dendorfer, A., Heidbreder, M., Hellwig-Bürgel, T., Jöhren, O., Qadri, F., & Dominiak, P. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.015 · Cited by 68
Research works printed but not linked: 63
- L Blonde, Improving care for patients with type 2 diabetes: Applying management guidelines and algorithms, and a review of new evidence for incretin agents and lifestyle intervention. Am J Manag Care 17, S368–S376 (2011).
- 10.1016/j.amjcard.2011.03.017 · DOI
- 10.2337/dc12-2625 · DOI · Paper page
- 10.1016/j.mvr.2013.05.004 · DOI
- 10.1172/JCI32169 · DOI · Paper page
- 10.1016/S0002-9610(03)00285-X · doi:10.1016/s0002-9610(03)00285-x
- 10.2337/dc12-2712 · DOI
- 10.3402/dfa.v4i0.21847 · DOI · Paper page
- 10.1016/j.apmr.2007.11.005 · DOI · Paper page
- 10.1177/1071100712467436 · doi:10.1177/1071100712467436
- 10.1161/01.CIR.0000039526.42991.93 · DOI · Paper page
- 10.1097/01.prs.0000244830.16906.3f · DOI
- 10.1073/pnas.0910561106 · DOI
- 10.1016/j.febslet.2012.04.032 · DOI
- 10.4161/cc.9.1.10371 · DOI · Paper page
- 10.1073/pnas.0906670106 · DOI · Paper page
- 10.1021/jm020412d · DOI
- BM Sundin, , The role of allopurinol and deferoxamine in preventing pressure ulcers in pigs. Plast Reconstr Surg 105, 1408–1421 (2000).
- 10.1002/1097-0347(200009)22:6<579::AID-HED6>3.0.CO;2-X · doi:10.1002/1097-0347(200009)22:6<579::aid-hed6>3.0.co;2-x
- 10.1021/cr00097a011 · DOI · Paper page
- 10.4103/0975-7406.92724 · DOI · Paper page
- S Kandavilli, V Nair, R Panchagnula, Polymers in transdermal drug delivery systems. Pharm Tech 26, 62–81 (2002).
- 10.1016/j.ejpb.2004.03.028 · DOI · Paper page
- 10.1016/j.jconrel.2008.05.006 · DOI
- 10.3109/02652049409034260 · doi:10.3109/02652049409034260
- 10.1081/DDC-120016678 · doi:10.1081/ddc-120016678
- 10.1016/S0378-5173(99)00363-4 · doi:10.1016/s0378-5173(99)00363-4
- 10.3109/03639049809085627 · DOI
- 10.1111/1523-1747.ep12533356 · DOI · Paper page
- 10.1016/0378-5173(95)00141-5 · DOI · Paper page
- 10.1080/08941930490472046 · DOI · Paper page
- 10.1002/med.10024 · DOI · Paper page
- 10.1016/j.cardiores.2003.12.023 · DOI · Paper page
- 10.1016/S0002-9610(03)00306-4 · DOI · Paper page
- 10.1161/CIRCINTERVENTIONS.111.966226 · DOI
- 10.1016/j.phrs.2008.06.004 · DOI · Paper page
- 10.1007/978-1-59745-571-8 · DOI
- 10.1517/14712598.2.2.211 · DOI
- 10.2165/11534570-000000000-00000 · DOI
- EA Knowles, , Offloading diabetic foot wounds using the scotchcast boot: A retrospective study. Ostomy Wound Manage 48, 50–53 (2002).
- JC Dumville, S Deshpande, S O’Meara, K Speak, Foam dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev, pp. CD009111 (2011).
- 10.1111/j.1742-481X.2008.00471.x · DOI · Paper page
- JC Dumville, S Deshpande, S O’Meara, K Speak, Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 8, CD009099 (2013).
- 10.1097/00004647-200205000-00003 · DOI · Paper page
- 10.1089/jop.2008.0082 · DOI
- 10.1016/0014-5793(90)80786-I · DOI
- 10.1038/nbt.1504 · DOI · Paper page
- 10.1080/10717540500455975 · DOI · Paper page
- 10.1038/nrd1304 · DOI · Paper page
- 10.1002/1520-6017(200012)89:12<1525::AID-JPS3>3.0.CO;2-T · doi:10.1002/1520-6017(200012)89:12<1525::aid-jps3>3.0.co;2-t
- 10.1016/j.addr.2012.09.032 · DOI · Paper page
- 10.1016/j.addr.2003.10.026 · DOI · Paper page
- 10.1016/S0378-5173(02)00299-5 · doi:10.1016/s0378-5173(02)00299-5
- 10.1016/j.addr.2003.10.027 · DOI · Paper page
- 10.1016/j.actbio.2013.04.045 · doi:10.1016/j.actbio.2013.04.045
- 10.1007/s11095-005-2498-6 · doi:10.1007/s11095-005-2498-6
- 10.1186/1741-7015-2-12 · doi:10.1186/1741-7015-2-12
- 10.1039/c2nr11606e · DOI
- Y Yang, J Bugno, S Hong, Nanoscale polymeric penetration enhancers in topical drug delivery. Polym Chem, 2013).
- 10.1039/c0sm00272k · DOI
- 10.1073/pnas.1118425109 · DOI · Paper page
- 10.1016/j.biomaterials.2013.09.092 · DOI
- 10.1097/SHK.0000000000000210 · DOI
Cited by
Wound Healing: A Cellular Perspective
Rodrigues, M., Kosaric, N., Bonham, C. A., & Gurtner, G. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00067.2017 · Cited by 3,013
Self-citationWound healing: cellular mechanisms and pathological outcomes
Wilkinson, H. N., & Hardman, M. J. (2020) · Open Biology · doi:10.1098/rsob.200223 · Cited by 1,796
Therapeutic strategies for enhancing angiogenesis in wound healing
Veith, A. P., Henderson, K., Spencer, A., Sligar, A. D., & Baker, A. B. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.010 · Cited by 1,021
Macro‐ and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Shi, Y., & Vanhoutte, P. M. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12521 · Cited by 545
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
“Inhibited HIF-1α signaling impairs wound healing, while activated HIF-1α signaling increases fibroblast proliferation, migration, and angiogenesis to promote wound healing in the diabetes animal models.(168,173,174) Properly activated HIF-1α signaling is critical for diabetic heart disease.”
Background
Metadata
- Authors
- Duscher, D., Neofytou, E., Wong, V. W., Maan, Z. N., Rennert, R. C., Inayathullah, M., Januszyk, M., Rodrigues, M., Malkovskiy, A. V., Whitmore, A. J., Walmsley, G. G., Galvez, M. G., Whittam, A. J., Brownlee, M., Rajadas, J., & Gurtner, G. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-12-22
- Volume
- 112
- Issue
- 1
- Pages
- 94-99
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2006016787
- Cited by
- 226
- References
- 9
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (RO1-DK-074095, RO3-DK-09452101)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.